• 1
    Grigsby PW. PET/CT imaging to guide cervical cancer therapy. Future Oncol. 2009; 5: 953-958.
  • 2
    Lai CH, Yen TC, Ng KK. Surgical and radiological staging of cervical cancer. Curr Opin Obstet Gynecol. 2010; 22: 15-20.
  • 3
    Schwartz JK, Siegel BA, Dehdashti F, et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007; 298: 2289-2295.
  • 4
    Schwartz JK, Linn LL, Siegel BA, et al. 18-F-deoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2008; 72: 1502-1507.
  • 5
    Brooks RA, Rader J, Dehdashti F, et al. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol. 2009; 112: 104-109.
  • 6
    Beyer T, Townsend DW, Brun T, et al. A combined PET/CT tomograph for clinical oncology. J Nucl Med. 2000; 41: 1369-1379.
  • 7
    Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer. 2006; 106: 914-922.
  • 8
    Pandharipande PV, Choy G, del Carmen MG, et al. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes. AJR Am J Roentgenol. 2009; 192: 802-814.
  • 9
    Chung HH, Kang KW, Cho JY, et al. Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer. Am J Obstet Gynecol. 2010; 203: 156.e1-e5.
  • 10
    Narayan K, Hicks RJ, Jobling T, et al. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer. 2001; 11: 263-271.
  • 11
    Yoshida Y, Kurokawa T, Kawahara K, et al. Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-fluorodeoxyglucose positron emission tomography: preliminary results in three patients. Gynecol Oncol. 2004; 95: 597-602.
  • 12
    Motton S, De Lapparent T, Brenot-Rossi I, et al. 18-Fluoro-2deoxy-d-glucose-positron emission tomography and locally advanced cervical cancer. Int J Gynecol Cancer. 2009; 19: 8-12.
  • 13
    Testa AC, Ludovisi M, Manfredi R, et al. Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. Ultrasound Obstet Gynecol. 2009; 34: 335-344.
  • 14
    Manfredi R, Maresca G, Smaniotto D, et al. Cervical cancer response to neoadjuvant therapy: MR imaging assessment. Radiology. 1998; 209: 819-824.
  • 15
    Vincens E, Balleyguier C, Rey A, et al. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy. Cancer. 2008; 113: 2158-2165.
  • 16
    Ferrandina G, Distefano M, Ludovisi M et al. Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy. Ann Surg Oncol. 2007; 14: 1129-1135.
  • 17
    McNeil C. New standard of care for cervical cancer sets stage for next questions. J Natl Cancer Inst. 1999; 91: 500-501.
  • 18
    Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials. Eur J Cancer. 2003; 39: 2470-2486.
  • 19
    Classe JM, Rauch P, Rodier JF, et al. Groupe des Chirurgiens de Centre de Lutte Contre le Cancer. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol. 2006; 102: 523-529.
  • 20
    Ferrandina G, Legge F, Fagotti A, et al. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome and prognostic measures. Gynecol Oncol. 2007; 107( suppl 1): S127-S132.
  • 21
    Motton S, Houvenaeghel G, Delannes M, et al. Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy. Int J Gynecol Cancer. 2010; 20: 268-275.
  • 22
    Touboul C, Uzan C, Mauguen A, et al. Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist. 2010; 15: 405-415.
  • 23
    Buda A, Fossati R, Colombo N, et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol. 2005; 23: 4137-4145.
  • 24
    Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974; 44: 265-272.
  • 25
    Fagotti A, Fanfani F, Rossitto C, et al. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy. Oncology. 2008; 75: 152-158.
  • 26
    Zannoni GF, Vellone VG, Carbone A. Morphological effects of radiochemotherapy on cervical carcinoma: a morphological study of 50 cases of hysterectomy specimens after neoadjuvant treatment. Int J Gynecol Pathol. 2008; 27: 274-281.
  • 27
    Scambia G, Ferrandina G, Distefano M, et al. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients? Gynecol Oncol. 2001; 83: 319-324.
  • 28
    Ferrandina G, Margariti PA, Smaniotto D, et al. Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. Gynecol Oncol. 2010; 119: 404-410.
  • 29
    Ferrandina G, Fanfani F, Ludovisi M, et al. Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? Gynecol Oncol. 2008; 108: 220-225.
  • 30
    Kim SK, Choi HJ, Park SY, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. Eur J Cancer. 2009; 45: 2103-2109.